Dax D.

Dax D. has a strong background in program management and leadership roles within the biotechnology and pharmaceutical industries. Starting in 1998 at Bayer HealthCare, they conducted process development and led a technology transfer team. From 2004 to 2006, they worked at Wyeth as a Technology Scientist and Six Sigma Project lead. At Amgen from 2006 to 2008, they served as a Project Manager, overseeing multiple cross-functional projects. From 2008 to 2014, at Algenol Biofuels, Inc., they directed the Program Management Organization and managed a DOE grant project. At MedImmune from 2014 to 2016, they were an Associate Director, responsible for alliance management and strategic management of the Immuno-Oncology pipeline. At Arthrex from 2016 to 2017, they were a Product Manager, driving product strategy related to Orthobiologic products. From 2018 to 2019 at Takeda, they worked in Global Program Management for Gastroenterology. From 2019 to 2021 at H3 Biomedicine, they served as the Director of Global Program Management for Oncology. Most recently, since 2021, they have been at Kymera Therapeutics and AVEO Oncology, holding senior director roles in Global Program Management for Oncology.

Dax D. obtained a Bachelor of Science degree in Microbiology from Indiana University Bloomington, where they studied from 1990 to 1994. Dax went on to pursue a Master of Science degree in Molecular Physiology & Biological Physics from the University of Virginia, completing their studies from 1996 to 1998. In addition to their formal education, Dax D. holds certifications as a Project Management Professional (PMP), obtained from the Project Management Institute in March 2008, and as a Six Sigma Green Belt, obtained from NC State University in June 2006.